PLA2G7, caloric restriction and cardiovascular aging

© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

[1]  E. Ravussin,et al.  Caloric restriction in humans reveals immunometabolic regulators of health span , 2022, Science.

[2]  H. White,et al.  Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events , 2021, Diabetologia.

[3]  Tie-gang Li,et al.  Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation , 2021, Acta Pharmacologica Sinica.

[4]  D. Ojcius,et al.  Recent advances in the field of caloric restriction mimetics and anti-aging molecules , 2020, Ageing Research Reviews.

[5]  I. Sjaastad,et al.  NLRP3 inflammasome deficiency attenuates metabolic disturbances involving alterations in the gut microbial profile in mice exposed to high fat diet , 2020, Scientific Reports.

[6]  W. Kraus,et al.  2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. , 2019, The lancet. Diabetes & endocrinology.

[7]  M. Lindsey,et al.  Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction , 2017, Translational research : the journal of laboratory and clinical medicine.

[8]  I. A. de Medeiros,et al.  Aging: Molecular Pathways and Implications on the Cardiovascular System , 2017, Oxidative medicine and cellular longevity.

[9]  K. Limesand,et al.  Lifespan-extending caloric restriction or mTOR inhibition impair adaptive immunity of old mice by distinct mechanisms , 2014, Aging cell.

[10]  P. Pais,et al.  Darapladib for preventing ischemic events in stable coronary heart disease. , 2014, The New England journal of medicine.

[11]  S. Duan,et al.  Elevated PLA2G7 Gene Promoter Methylation as a Gender-Specific Marker of Aging Increases the Risk of Coronary Heart Disease in Females , 2013, PloS one.

[12]  H. Hakonarson,et al.  Translational studies of lipoprotein-associated phospholipase A₂ in inflammation and atherosclerosis. , 2012, Journal of the American College of Cardiology.

[13]  A. Tselepis,et al.  The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. , 2009, Biochimica et biophysica acta.

[14]  D. Kristan.  Calorie restriction and susceptibility to intact pathogens , 2008, AGE.

[15]  G. Zimmerman,et al.  Anti-inflammatory properties of a platelet-activating factor acetylhydrolase , 1995, Nature.

[16]  Hang Shi,et al.  Changes in adipose tissue macrophages and T cells during aging. , 2014, Critical reviews in immunology.

[17]  J. Speakman,et al.  Caloric restriction. , 2011, Molecular aspects of medicine.

[18]  E. Lakatta.  Age-associated Cardiovascular Changes in Health: Impact on Cardiovascular Disease in Older Persons , 2004, Heart Failure Reviews.

[19]  From the Centers for Disease Control and Prevention. Public health and aging: trends in aging--United States and worldwide. , 2003, JAMA.

[20]  Trends in aging--United States and worldwide. , 2003, MMWR. Morbidity and mortality weekly report.